期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Introduction. The aim of this study was to evaluate the practicality of the signal transducer and activator of transcription (STAT) 3 polymorphisms as......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
What Is Known and Objective. The primary cause of trabeculectomy failure in glaucoma surgery is the imperfect formation of the filter bubble, which bl......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Background. Vonoprazan is a novel selective and noncompetitive oxidative-reduction state proton pump inhibitor (PPI), known as a potassium-competitive......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Objective. Neuromuscular blocking agents (NMBAs) are part of the three elements of general anaesthesia (sedation, analgesia, and muscle relaxation), w......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Onjisaponin B (OB) is the main active ingredient of Radix Polygalae with various bioactivities. However, the protective effect of OB in Parkinson's di......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Objectives. To investigate adverse events (AEs) associated with upadacitinib in the real world using data mining from the FDA Adverse Event Reporting ......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
What is Known and Objective. To explore the effects of traditional Chinese medicine (TCM) combined with levothyroxine (L-T4) on thyroid autoantibodies......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
What Is Known and Objective. CYP2C19 is an important influencing factor for voriconazole trough plasma concentration (C-min); however, it is not verif......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Background. Various antibiotics are prescribed empirically by physicians to cope with infections in renal disease patients. A urinary tract infection ......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Sepsis, a critical medical condition instigated by infections, profoundly alters molecular and cellular immune responses. This study focused on the GS......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
What Is Known? In elderly inpatients, potential inappropriate medication (PIM) is a prominent prescription challenge. However, there is limited inform......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Objective. Metformin is a common antidiabetic drug that has been reported to serve as an anticancer agent in combination with other therapies. But the......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease. Previous studies have shown that dihydromyricetin (DHM) is beneficial for NAFLD. ......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
The use of standard synthetic medications to treat inflammatory illnesses is associated with several negative effects. It has been shown that medicina......
期刊： JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2023; 2023 ()
Background. NUDT15 gene polymorphisms have been identified to predispose Asian patients with an inflammatory bowel disease (IBD) to thiopurine-induced......
